Correction: ECMO for ARDS: from salvage to standard of care? (The Lancet Respiratory Medicine (2019) 7(2) (108–110), (S221326001830506X) (10.1016/S2213-2600(18)30506-X));ECMO for ARDS: from salvage to standard of care?

The Lancet Respiratory Medicine

Volumn 7, Issue 2, 2019, Pages 108-110

  Abrams, Darryl ^a,b   Ferguson, Niall D ^c,d   Brochard, Laurent ^c,e   Fan, Eddy ^c,d   Mercat, Alain ^f   Combes, Alain ^g,h   Pellegrino, Vin ⁱ   Schmidt, Matthieu ^g,h   Slutsky, Arthur S ^c,e   Brodie, Daniel ^a,b  

^a Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital ^*  (United States)

^b NewYork Presbyterian Hospital   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f ANGERS UNIVERSITY HOSPITAL   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^h SORBONNE UNIVERSITÉ   (France)

ⁱ ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ALGORITHM; ARTIFICIAL VENTILATION; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; HEART FAILURE; HUMAN; HYPOXEMIA; INTENSIVE CARE; MORTALITY; NOTE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PRONE POSITION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; SALVAGE THERAPY; TREATMENT INDICATION; DYSPNEA; HEALTH CARE QUALITY;

DYSPNEA; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT; STANDARD OF CARE;

EID: 85060534820     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(19)30008-6     Document Type: Erratum

References (12)

1. Combes, A, Hajage, D, Capellier, G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 378 (2018), 1965–1975.
2. Harrington, D, Drazen, JM, Learning from a trial stopped by a data and safety monitoring board. N Engl J Med 378 (2018), 2031–2032.
3. Goligher, EC, Tomlinson, G, Hajage, D, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial. JAMA 320 (2018), 2251–2259.
4. Munshi, L, Walkey, A, Goligher, E, Pham, T, Uleryk, E, Fan, E, Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med, 2019 published online Jan 11. http://dx.doi.org/10.1016/S2213-2600(18)30452-1.
5. Derwall, M, Rossaint, R, ECMO in severe acute respiratory distress syndrome: a light at the end of the tunnel?. Lancet Respir Med 6 (2018), 661–662.
6. Brodie, D, Guerin, C, Rescue therapy for refractory ARDS should be offered early: no. Intensive Care Med 41 (2015), 926–929.
7. Bellani, G, Laffey, JG, Pham, T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315 (2016), 788–800.
8. Li, X, Scales, DC, Kavanagh, BP, Unproven and expensive before proven and cheap—extracorporeal membrane oxygenation vs prone position in ARDS. Am J Respir Crit Care Med 197 (2018), 991–993.
9. Abrams, D, Fan, E, Ferguson, ND, Brodie, D, Unproven and expensive may still be justifiable. Am J Respir Crit Care Med, 198, 2018, 140.
10. Hardin, CC, Hibbert, K, ECMO for Severe ARDS. N Engl J Med 378 (2018), 2032–2034.
11. Combes, A, Brechot, N, Luyt, CE, Schmidt, M, Extracorporeal membrane oxygenation: beyond rescue therapy for acute respiratory distress syndrome?. Curr Opin Crit Care 23 (2017), 60–65.
12. Lewis, RJ, Angus, DC, Time for clinicians to embrace their inner Bayesian?: reanalysis of results of a clinical trial of extracorporeal membrane oxygenation. JAMA 320 (2018), 2208–2210.